about
Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries.Dramatic effect of early clopidogrel administration in reducing mortality and MACE rates in ACS patients. Data from the Swiss registry AMIS-Plus.Myocardial infarct size and mortality depend on the time of day-a large multicenter studyOutcome of patients admitted with acute coronary syndrome on palliative treatment: insights from the nationwide AMIS Plus Registry 1997-2014.Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland: six year results from a nationwide registry.Age- and Gender-related Disparities in Primary Percutaneous Coronary Interventions for Acute ST-segment elevation Myocardial InfarctionGender differences in management and outcomes in patients with acute coronary syndromes: results on 20,290 patients from the AMIS Plus Registry.Temporal trends in treatment of ST-elevation myocardial infarction among men and women in Switzerland between 1997 and 2011.Gender-related mortality trends among diabetic patients with ST-segment elevation myocardial infarction: insights from a nationwide registry 1997-2010Assessing the impact of DRGs on patient care and professional practice in Switzerland (IDoC) - a potential model for monitoring and evaluating healthcare reform.Management and outcome of patients with acute myocardial infarction presenting with pacemaker rhythm.Cost of acute coronary syndrome in Switzerland in 2008.Impact of a nationwide public campaign on delays and outcome in Swiss patients with acute coronary syndrome.Age-related differences in the use of guideline-recommended medical and interventional therapies for acute coronary syndromes: a cohort study.Comparison of in-hospital mortality for acute myocardial infarction in Switzerland with admission during routine duty hours versus admission during out of hours (insight into the AMIS plus registry).Is pretreatment with Beta-blockers beneficial in patients with acute coronary syndrome?Acute coronary syndromes in young patients: presentation, treatment and outcome.Impact of a normal or non-specific admission ECG on the treatment and early outcome of patients with myocardial infarction in Swiss hospitals between 2003 and 2008.Primary percutaneous coronary intervention for unprotected left main disease in patients with acute ST-segment elevation myocardial infarction the AMIS (Acute Myocardial Infarction in Switzerland) plus registry experience.Characteristics and Outcome in Acute Coronary Syndrome Patients with and without Established Modifiable Cardiovascular Risk Factors: Insights from the Nationwide AMIS Plus Registry 1997-2010.Treatment and outcomes of patients with recurrent myocardial infarction: A prospective observational cohort study.Drug-eluting stents compared to bare-metal stents improve short-term survival in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a nationwide prospective analysis of the AMIS Plus registry.Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: a nationwide study cohort from the AMIS Plus registry.Inpatient versus outpatient onsets of acute myocardial infarction.Impact of hypertension on the outcome of patients admitted with acute coronary syndrome.Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry.Incidence of acute myocardial infarction after implementation of a public smoking ban in Graubünden, Switzerland: two year follow-up.Admission glycaemia and outcome in patients with acute coronary syndrome.AMIS Plus: Swiss registry of acute coronary syndrome.Impact of Body Mass Index on mortality in Swiss hospital patients with ST-elevation myocardial infarction: does an obesity paradox exist?The impact of statin treatment on presentation mode and early outcomes in acute coronary syndromes.Centenarians with acute coronary syndrome - Biological and not chronological age counts.Simple point-of-care risk stratification in acute coronary syndromes: the AMIS model.Determinants of costs and the length of stay in acute coronary syndromes: a real life analysis of more than 10,000 patients.Dose-dependent toxicity of diphenhydramine overdose.Lower age at first myocardial infarction in female compared to male smokers.Referral for cardiac rehabilitation after acute myocardial infarction: Insights from nationwide AMIS Plus registry 2005–2017Gender Difference in the Application of Reperfusion Therapy in Patients with Acute Myocardial InfarctionDie Behandlung des akuten Koronarsyndroms heute und in ZukunftAssociation of Dyslipidemia and Concomitant Risk Factors with In-Hospital Mortality in Acute Coronary Syndrome in Switzerland
P50
Q33788973-E29C6EA2-C76A-49E7-AD57-2DCFA36E33D3Q34264239-50DDF281-0D21-4F8F-BD31-A387860ABFACQ35168315-44E7C646-9DC0-4EC5-AD2B-9AE4E5C7519FQ35179910-FDBCF7DB-A26E-47B7-A448-7BC8A6CA5D83Q35584414-E9BC142D-1111-4E3A-81C1-D994777EE7A8Q35767879-A9930D24-B80C-4F78-9A73-30018A692044Q36057128-DAF93E4F-E413-47A2-9BBF-2FDC7B447413Q37140914-D053BFFA-1AC9-4B0C-AE57-79AB6CB12410Q37291908-E6C0E47E-98D1-4C9F-BE95-E199CBBF39EAQ39041373-E181488D-EE8D-4ADA-B18D-B3AAAF35EE22Q39046765-D892ADEB-2512-4423-A9A2-1456BE2C99D8Q39564938-E3124C11-0BD1-4AF4-B875-808487D76B34Q39765859-27F9D202-FE8D-45DA-83F0-74E1AADBF28AQ39828010-EF6E1D44-2F33-4EBA-9474-0EE216BCD635Q39837205-937F7B5B-5AB1-49B7-8459-D38090049579Q39907384-AB5230BC-B53B-4E08-9320-4E7D7EF4365BQ39909371-8E64EE38-5707-4DE2-AD0D-160896956136Q39948061-48EC9E7E-21F8-4281-A0C3-31D7EC2A12A6Q39988371-E9A9B4C6-01F1-466B-8E59-942787E6FFD5Q40033812-3B220E6B-A2A4-4970-BFAA-0F98A26BDB22Q40096053-DC5A852F-FD40-4D72-B297-0CB8140E24BEQ40154511-2E82B427-A191-4946-8CBF-615DEF0AEC09Q40166544-2EB19B24-5535-4834-B366-8B4CF248ADD9Q40284948-DC36058E-268B-46BB-B50D-29C5CB2A0E50Q41009821-A7692C82-779F-4F9E-8D65-4087D022EF88Q41538436-FC04017B-8C46-4573-AAE9-ADD266F97622Q43498494-E7B683A6-AF77-4669-A543-3CEBFAA54C04Q43832101-417A5E6C-7EE0-4994-8DD6-0484DAFE8FF6Q43847022-1B0FDB37-0616-4122-8560-AFE0650258A6Q43849015-4065AD76-0DC6-43E2-B62D-5955AC21F982Q44062888-D1098DD9-301F-4F73-AD74-CB900E7D95B0Q44505165-44CEF30C-606D-451C-8AEE-41F988447438Q45964209-A0198CE9-C4B7-4273-8295-4BCF4C0E67FFQ50146184-23A11554-288F-4DFB-8555-9DC7D197E555Q51365140-B33DBC84-B957-4954-8769-20BA64BC9840Q51411955-263465D0-0D9B-4C19-BEFA-16092AE0500AQ60198128-48D20631-4B06-4776-9560-58E50E9C3A71Q60198223-86639B26-7FC9-487E-8FB4-0F99BE66AA02Q60198231-7D73D0FA-7B0C-4AB5-9872-A27918C26D16Q60198257-71F523E0-FE8D-4432-A31B-7EC62ED81D07
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dragana Radovanovic
@ast
Dragana Radovanovic
@en
Dragana Radovanovic
@es
Dragana Radovanovic
@nl
Dragana Radovanovic
@sl
type
label
Dragana Radovanovic
@ast
Dragana Radovanovic
@en
Dragana Radovanovic
@es
Dragana Radovanovic
@nl
Dragana Radovanovic
@sl
altLabel
Ivosevic
@en
prefLabel
Dragana Radovanovic
@ast
Dragana Radovanovic
@en
Dragana Radovanovic
@es
Dragana Radovanovic
@nl
Dragana Radovanovic
@sl
P1053
F-7908-2013
P106
P21
P31
P3829
P496
0000-0002-9507-6272